The global minimally invasive neurosurgical market is expected to witness a CAGR of 11.5% during the forecast period. The preference for minimally invasive neurosurgeries has led to the emergence of robot-assisted surgeries owing to the requirement for millimeter accuracy and precision. The technological advancement, changes in the preference for safe options rather than open brain surgeries, rising preference for surgical instruments with high dexterity, technological development in AI, AR, haptics, and telesurgery, and rising affordability of procedure will propel the growth of the global minimally invasive neurosurgical systems market.

COVID-19 pandemic had significantly impacted the Minimally Invasive Neurosurgery Device Market. Owing to a pandemic, healthcare equipment is preserved for patients infected with the coronavirus that increases delays in neurosurgeries owing to the high risk of getting infected, and are negatively affected the growth of this market.

Download Free Sample Copy Of Research Report: https://www.vynzresearch.com/healthcare/minimally-invasive-neurosurgical-systems-market/request-sample

Olympus Corporation has launched EVIS X1, an advanced endoscopy system that helps in improving the outcomes from endoscopic disorders.

Karl Storz GmbH & Co. KG has installed six examination rooms specialized for ENT treatment that increases the demand of minimally invasive procedures.

Based on product type, the global minimally invasive neurosurgical systems market is divided into neuro microscope, neuronavigation, neuroendoscopy, and neurosurgical robots. The neurosurgical robots are further sub-divided into systems (capital equipment), instruments and accessories, and services. Neurosurgical robots are growing at a faster pace as they help surgeons to perform complex surgeries will high flexibility and precision. Moreover, robotic surgeries will provide various advantages including few complications in terms of pain and blood loss, less risk of surgical site infection, quick recovery, and small scars.

Asia-Pacific is anticipated to have a high CAGR for the minimally invasive neurosurgery system market during the forecast period 2021-2027 owing to the increasing disposable income and support from the government towards enhancing the healthcare sector.

Some of the key players operating in the minimally invasive neurosurgery system market: Olympus Corporation, B. Braun Melsungen AG, Karl Storz SE & Co. KG, Brainlab AG, Carl Zeiss Meditec AG, Medtronic, Microbat Medical Inc., Stryker, Zimmer Biomet, and Synaptive Medical.

Source: VynZ Research